DEFENCATH (TAUROLIDINE/HEPARIN) Trademark

Trademark Overview

On Thursday, June 10, 2021, a trademark application was filed for DEFENCATH (TAUROLIDINE/HEPARIN) with the United States Patent and Trademark Office. The USPTO has given the DEFENCATH (TAUROLIDINE/HEPARIN) trademark a serial number of 90766807. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by CorMedix Inc.. The DEFENCATH (TAUROLIDINE/HEPARIN) trademark is filed in the Pharmaceutical Products category with the following description:

Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution
defencath (taurolidine/heparin)

General Information

Serial Number90766807
Word MarkDEFENCATH (TAUROLIDINE/HEPARIN)
Filing DateThursday, June 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized words "DEFENCATH (TAUROLIDINE/HEPARIN)" with the letter "C" in the word DEFENCATH appearing in an un-outlined circle, and the words "(TAUROLIDINE/HEPARIN)" positioned below the word "DEFENCATH".
Goods and ServicesAntimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution
NOT AVAILABLE"(TAUROLIDINE/HEPARIN)"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCorMedix Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameCorMedix Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Trademark Events

Event DateEvent Description
Monday, June 14, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 2, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, March 21, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 23, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 23, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2022SOU EXTENSION 1 FILED
Friday, December 16, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2023SOU EXTENSION 2 GRANTED
Thursday, June 15, 2023SOU EXTENSION 2 FILED
Saturday, June 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

heparin taurolidine defencath solution catheter lock both containing antimicrobial